About the FDA Public-Private Partnerships Program
The FDA Public-Private Partnerships Program is dedicated to leading the creation, implementation and management of strategic collaborations that leverage expertise and resources from FDA and other organizations to protect and promote public health. This program serves as an agency-wide resource, of highly skilled and experienced staff, to all Centers/Offices within FDA and to all non-FDA partners.
- Public-Private Partnerships (PPPs) represent an economically compelling way for FDA and stakeholders to leverage combined resources and know-how, collaboratively and under aligned missions, for the benefit of public health. There are numerous business models that may be developed to facilitate different PPPs depending on the scientific goals, the resources available, the partners involved and the different leveraging mechanisms used (see: The Leveraging Handbook). Regardless of their scope, and objectives, PPPs achieve synergies in which the whole is greater than the sum of the parts/partners. Because PPPs represent a mechanism for FDA to accomplish its mission, staff involvement in PPPs represent official duty activities. See: Roles and Responsibilities for FDA Employees Interacting with an Outside Organization under a PPP
- FDA’s Public-Private Partnerships allow the FDA to partner with any number of a wide range of other organizations including, but not limited to, patient advocacy groups, professional societies, charitable foundations, industry members, trade organizations, academic institutions and other government and state entities.
- FDA’s Public-Private Partnerships are science-driven, aim to improve the public health, and are structured to uphold the principles of transparency, fairness, inclusiveness, scientific rigor, and compliance with Federal laws and FDA policy.
- The PPP Program resides within the Office of the Commissioner as a reflection of its overarching mission to support and work on behalf of all FDA Centers and Offices.